Details for New Drug Application (NDA): 202057
✉ Email this page to a colleague
The generic ingredient in VASCEPA is icosapent ethyl. There are twelve drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the icosapent ethyl profile page.
Summary for 202057
Tradename: | VASCEPA |
Applicant: | Amarin Pharms |
Ingredient: | icosapent ethyl |
Patents: | 63 |
Suppliers and Packaging for NDA: 202057
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057 | NDA | Amarin Pharma Inc. | 52937-001 | 52937-001-04 | 4 CAPSULE in 1 BOTTLE (52937-001-04) |
VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057 | NDA | Amarin Pharma Inc. | 52937-001 | 52937-001-20 | 120 CAPSULE in 1 BOTTLE (52937-001-20) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 1GM | ||||
Approval Date: | Jul 26, 2012 | TE: | AB | RLD: | Yes | ||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 29, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF VASCEPA TO LOWER TRIGLYCERIDES IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 29, 2030 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF VASCEPA TO REDUCE TRIGLYCERIDES IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON ROSUVASTATIN THERAPY | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jun 28, 2033 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF CORONARY REVASCULARIZATION AND/OR UNSTABLE ANGINA IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE LEVELS (TG >= 150 MG/DL TO ABOUT 500 MG/DL) |
Expired US Patents for NDA 202057
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription